Open Close

OmniComm Systems expands market presence in Asia

OmniComm Systems, Inc. (OTC: OMCM) said it has signed a five-year agreement with Seoul National University Hospital Clinical Trials Center to use OmniComm Systems´ market leading TrialOne technology for automation within its Phase I clinical pharmacology studies.

Seoul National University Hospital has been looking after public health over the past 100 years, leading the development of medicine in Korea. It was established in 1885 as Korea´s first national hospital under the name of Kwang Hye Won. Later it became the affiliate hospital for Seoul National University´s College of Medicine and College of Dentistry before being recognized as a special corporate body under the name of Seoul National University Hospital. For more information, visit

OmniComm Systems is a leading strategic software solutions provider to the life sciences industry. The company provides comprehensive solutions for clinical research with an extensive global experience from over 4,000 clinical trials. For more information, visit


If you enjoyed this post, please consider leaving a comment or subscribing to the RSS feed to have future articles delivered to your feed reader.